Controversies of hepatectomy and adjuvant therapy for hepatocellular carcinoma: moving forward

• 作者: Bang-De Xiang Jian-Hong Zhong
• 来源期刊: 肝癌研究（英文版）
• 年，卷（期）: 2019,（6）
• 所属期刊栏目: Editorial
• 页码范围: 1-6
• 页数: 6页
• 语种: 英文
• DOI: 10.20517/2394-5079.2019.01

摘要

Due to the prevelence of hepatitis B virus (HBV) and hepatitis C virus (HCV), occurrence of hepatocellular carcinoma (HCC) is increasing in many countries/regions, including China[1].